Recruiting NA INTERVENTIONAL 2-arm NCT05775419

Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

A Prospective Randomized Controlled Clinical Study Comparing Curative Effect of Non-surgical Esophageal Squamous Cell Carcinoma With Radical Chemoradiotherapy and Radical Chemoradiotherapy Combined With Consolidation Chemotherapy

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Conditions Chemotherapy Effect Esophageal Squamous Cell Carcinoma Side Effect of Drug

Interventions Concurrent chemotherapy (2 courses) Consolidation chemotherapy (4 courses)

Updated 3 times since 2023 Last updated: Mar 16, 2023 Started: Jun 30, 2021 Primary completion: Jun 30, 2025 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05775419, this NA trial focuses on Chemotherapy Effect and Esophageal Squamous Cell Carcinoma and remains actively recruiting participants. Sponsored by The First Affiliated Hospital with Nanjing Medical University, it has been updated 3 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The First Affiliated Hospital with Nanjing Medical University

Data source: The First Affiliated Hospital with Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China